NASDAQ:OBSV

ObsEva (OBSV) Stock Price, News & Analysis

$0.0050
0.00 (0.00%)
(As of 04/22/2024 ET)
Today's Range
$0.0050
$0.0050
50-Day Range
$0.00
$0.08
52-Week Range
$0.08
$2.14
Volume
7,009 shs
Average Volume
8.94 million shs
Market Capitalization
$389,855.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OBSV stock logo

About ObsEva Stock (NASDAQ:OBSV)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

OBSV Stock Price History

OBSV Stock News Headlines

StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
ObsEva Announces Update on Board of Directors
ObsEva SA OBSN
ObsEva SA OBSEF
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
ObsEva (NASDAQ: OBSV)
ObsEva Files Year End 2022 Financial Statements
Why Is ObsEva (OBSV) Stock Up 93% Today?
Why ObsEva (OBSV) Stock Is Down 36% Today
ObsEva Announces Dismissal of Moratorium Proceedings
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates
ObsEva SA (OBSV)
See More Headlines
Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OBSV
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Net Income
$-58,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.41 per share

Miscellaneous

Free Float
66,743,000
Market Cap
$389,855.00
Optionable
Not Optionable
Beta
0.68
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • William M. Brown
    Chief Executive & Financial Officer
  • Elke Bestel
    VP, Head-Drug Safety & Pharmacovigilance
  • Katja Buhrer
    Chief Strategy Officer

OBSV Stock Analysis - Frequently Asked Questions

How have OBSV shares performed in 2024?

ObsEva's stock was trading at $0.0350 at the beginning of the year. Since then, OBSV stock has decreased by 85.7% and is now trading at $0.0050.
View the best growth stocks for 2024 here
.

How were ObsEva's earnings last quarter?

ObsEva SA (NASDAQ:OBSV) released its quarterly earnings data on Thursday, November, 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.23.

What other stocks do shareholders of ObsEva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Trevena (TRVN), Zosano Pharma (ZSAN), Vaxart (VXRT), VBI Vaccines (VBIV), Bionano Genomics (BNGO) and ADMA Biologics (ADMA).

When did ObsEva IPO?

ObsEva (OBSV) raised $98 million in an IPO on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners served as the underwriters for the IPO.

How do I buy shares of ObsEva?

Shares of OBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OBSV) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners